Canadian Investment Regulatory Organization Trade Resumption – HBP
TORONTO, April 1, 2024 /CNW/ – Trading resumes in:
Company: Helix BioPharma Corp.
TSX Symbol: HBP
All Issues: Yes
Resumption (ET): 9:00 AM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions
You may also like
Europe Cancer Diagnostics Market Sees Promising Growth Amid Rising Demand for Precision Diagnostics – Forecasts to 2031
DUBLIN, March 1, 2024 /PRNewswire/ — The “Europe Cancer Diagnostics Market by Product (
Japan Social Commerce Market Intelligence Report 2024: GMV will Increase from $15.11 Billion in 2023 to Reach $24.63 Billion by 2029
DUBLIN, Feb. 13, 2024 /PRNewswire/ — The “Japan Social Commerce Market Intelligence and
Cardinality Partners with Oregon’s Department of Early Learning and Care to Modernize Child Care Provider Management System
GAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ — Cardinality.ai, an AI SaaS solutions provider
